LOTTE Biologics Tightens Global Quality as Syracuse ADC Hub Ramps for 2026

"With inspections always on the table, LOTTE Biologics is pushing a proactive, quality first culture across its dual hubs in Syracuse and Songdo, backing its new single‑use ADC facility with rigorous training, self‑audits and real‑time regulatory surveillance."
 

Emily Yourd, Associate Director, Quality Assurance Compliance at LOTTE Biologics, spoke with BioSpace about how the company takes a proactive, inspection-ready approach to building and sustaining a global quality culture—particularly as it continues to scale its ADC capabilities.
 

Read the full article: LOTTE Biologics Tightens Global Quality as Syracuse ADC Hub Ramps for 2026 - BioSpace